Studying the role of DSCC1 and GINS1 in clinical gastric cancer samples and their relationship with patient prognosis is of great significance for understanding the pathogenesis of gastric cancer and developing potential therapeutic strategies, which will help to more accurately evaluate the value of these two genes as potential therapeutic targets. This evidence concerns the gene DSCC1 and gastric cancer.